NAFDAC warns of counterfeit breast cancer drug Phesgo in Nigeria
ArchivedVerified|3 articles|3 sources|1 blocks
Detected: Updated: Analyzed:
Reported Facts
Observable data points shared across all narratives
- •NAFDAC issued a public alert on March 18, 2026, about counterfeit Phesgo in the Nigerian market.
- •On March 19, 2026, NAFDAC extended its warning to include fake Avastin and Tecentriq cancer drugs.
- •Counterfeit drugs were found circulating in various pharmacies and healthcare providers across Nigeria.
- •NAFDAC is conducting intensified inspections to identify and remove counterfeit cancer medications.
- •The counterfeit drugs threaten breast cancer patients by undermining treatment effectiveness and safety.
What Could Happen If...
- ▸If NAFDAC successfully removes counterfeit cancer drugs from the market then Nigerian breast cancer patients will have safer access to authentic medications, improving treatment outcomes and reducing health risks.
Key Actors
Countries
Instruments
Source Coverage
AFRICA
3 articles
More coverage on this story
- More on Nigeria
- More on Phesgo
- More on National Agency for Food and Drug Administration and Control
Signals
Single-block coverage
Related Events
▸NAFDAC warns of counterfeit Dostinex tablets in NigeriaArchived▸NAFDAC seizes banned cosmetics worth N3 billion in Lagos warehouseArchived▸AltBank Launches Non-Interest Financing to Boost Nigerian Drug ProductionArchived▸Nigeria NAFDAC recalls Aptamil and Cow & Gate infant formula batchesArchived▸NAFDAC recalls male enhancement capsules over safety concerns
Primary Sources (3)
AFRICAVanguard (Nigeria)Counterfeit cancer drugs: NAFDAC raises alarm over fake Avastin, TecentriqAFRICAAllAfrica - TopNigeria: NAFDAC Alerts Nigerians to Counterfeit Breast Cancer Drug Phesgo in NigeriaAFRICAPremium Times (Nigeria)NAFDAC alerts Nigerians to counterfeit breast cancer drug Phesgo in Nigeria